XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Class B Common Stock
Common Stock
Common Shares
Common Stock
Class B Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Common Shares
Retained Earnings
Class B Common Stock
Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 29, 2020 $ 1,741,129     $ 1,525 $ 364 $ 86,645 $ 1,684,565     $ (31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020       15,251 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 41,896           41,896      
Change in fair value of derivatives (21)                 (21)
Foreign currency translation 1,310                 1,310
Dividends declared Common Stock   $ (3,806) $ (729)         $ (3,806) $ (729)  
Repurchase of Common Stock (7,216)     $ (4)   (223) (6,989)      
Repurchase of common stock (in shares)       (41)            
Share-based compensation, net [1] 788         788        
Share-based awards exercised, net [2] 1     $ 1            
Share-based awards exercised, net (in shares) [2]       11            
Balance at end of period at Nov. 28, 2020 1,773,352     $ 1,522 $ 364 87,210 1,714,937     (30,681)
Balance at end of period (in shares) at Nov. 28, 2020       15,221 3,643          
Balance at beginning of period at Aug. 29, 2020 1,741,129     $ 1,525 $ 364 86,645 1,684,565     (31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020       15,251 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 116,497                  
Foreign currency translation 9,653                  
Balance at end of period at May. 29, 2021 1,845,199     $ 1,524 $ 364 87,545 1,778,212     (22,446)
Balance at end of period (in shares) at May. 29, 2021       15,243 3,643          
Balance at beginning of period at Nov. 28, 2020 1,773,352     $ 1,522 $ 364 87,210 1,714,937     (30,681)
Balance at beginning of period (in shares) at Nov. 28, 2020       15,221 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 32,585           32,585      
Change in fair value of derivatives (56)                 (56)
Foreign currency translation 2,244                 2,244
Dividends declared Common Stock   (3,806) (728)         (3,806) (728)  
Repurchase of Common Stock (2,318)     $ (1)   (66) (2,251)      
Repurchase of common stock (in shares)       (12)            
Share-based compensation, net [1] (165)         (165)        
Share-based awards exercised, net [2] 2     $ 2            
Share-based awards exercised, net (in shares) [2]       21            
Balance at end of period at Feb. 27, 2021 1,801,110     $ 1,523 $ 364 86,979 1,740,737     (28,493)
Balance at end of period (in shares) at Feb. 27, 2021       15,230 3,643          
Balance at beginning of period at Nov. 28, 2020 1,773,352     $ 1,522 $ 364 87,210 1,714,937     (30,681)
Balance at beginning of period (in shares) at Nov. 28, 2020       15,221 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income             42,016      
Balance at end of period at May. 29, 2021 1,845,199     $ 1,524 $ 364 87,545 1,778,212     (22,446)
Balance at end of period (in shares) at May. 29, 2021       15,243 3,643          
Balance at beginning of period at Feb. 27, 2021 1,801,110     $ 1,523 $ 364 86,979 1,740,737     (28,493)
Balance at beginning of period (in shares) at Feb. 27, 2021       15,230 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 42,016                  
Change in fair value of derivatives (52)                 (52)
Foreign currency translation 6,099                 6,099
Dividends declared Common Stock   (3,812) (729)         (3,812) (729)  
Share-based compensation, net [1] 566         566        
Share-based awards exercised, net [2] 1     $ 1            
Share-based awards exercised, net (in shares) [2]       13            
Balance at end of period at May. 29, 2021 1,845,199     $ 1,524 $ 364 87,545 1,778,212     (22,446)
Balance at end of period (in shares) at May. 29, 2021       15,243 3,643          
Balance at beginning of period at Aug. 28, 2021 1,872,952     $ 1,524 $ 364 89,257 1,806,643     (24,836)
Balance at beginning of period (in shares) at Aug. 28, 2021       15,236 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 33,705           33,705      
Change in fair value of derivatives 47                 47
Foreign currency translation (2,799)                 (2,799)
Dividends declared Common Stock   (4,566) (874)         (4,566) (874)  
Repurchase of Common Stock 4,771     $ 2   124 (4,645)      
Repurchase of common stock (in shares)       23            
Share-based compensation, net [1] 1,207         1,207        
Share-based awards exercised, net (in shares) [2]       7            
Balance at end of period at Nov. 27, 2021 1,894,901     $ 1,522 $ 364 90,340 1,830,263     (27,588)
Balance at end of period (in shares) at Nov. 27, 2021       15,220 3,643          
Balance at beginning of period at Aug. 28, 2021 1,872,952     $ 1,524 $ 364 89,257 1,806,643     (24,836)
Balance at beginning of period (in shares) at Aug. 28, 2021       15,236 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 77,223                  
Foreign currency translation (2,631)                  
Balance at end of period at May. 28, 2022 1,904,011     $ 1,512 $ 363 91,571 1,838,055     (27,490)
Balance at end of period (in shares) at May. 28, 2022       15,121 3,626          
Balance at beginning of period at Nov. 27, 2021 1,894,901     $ 1,522 $ 364 90,340 1,830,263     (27,588)
Balance at beginning of period (in shares) at Nov. 27, 2021       15,220 3,643          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 18,451           18,451      
Change in fair value of derivatives (55)                 (55)
Foreign currency translation 1,149                 1,149
Dividends declared Common Stock   (4,561) (870)         (4,561) (870)  
Repurchase of Common Stock (9,995)     $ (5)   (286) (9,704)      
Repurchase of common stock (in shares)       (53)            
Share-based compensation, net [1] (48)         (48)        
Share-based awards exercised, net [2] 3     $ 3            
Share-based awards exercised, net (in shares) [2]       25            
Shares converted       $ 1 $ (1)          
Shares converted (in shares)       17 (17)          
Balance at end of period at Feb. 26, 2022 1,898,975     $ 1,521 $ 363 90,006 1,833,579     (26,494)
Balance at end of period (in shares) at Feb. 26, 2022       15,209 3,626          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 25,067           25,067      
Change in fair value of derivatives (14)                 (14)
Foreign currency translation (982)                 (982)
Dividends declared Common Stock   $ (4,534) $ (870)         $ (4,534) $ (870)  
Repurchase of Common Stock (15,687)     $ (9)   (491) (15,187)      
Repurchase of common stock (in shares)       (90)            
Share-based compensation, net [1] 2,056         2,056        
Share-based awards exercised, net (in shares) [2]       2            
Balance at end of period at May. 28, 2022 $ 1,904,011     $ 1,512 $ 363 $ 91,571 $ 1,838,055     $ (27,490)
Balance at end of period (in shares) at May. 28, 2022       15,121 3,626          
[1] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.
[2] These amounts are shown net of the effect of income taxes.